Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Lisata Therapeutics (LSTA) appointed Jeffrey Farrow to its board of directors effective October 13, 2026, expanding the board from seven to eight members. Farrow is CFO and Chief Strategy Officer of Tarsus Pharmaceuticals and already serves as a director of Achieve Life Sciences (ACHV), where he chairs the audit committee. The announcement has no direct bearing on ACHV's operations, financials, or governance — it is background context about one of its existing directors taking on an additional board seat.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.